Computational Analysis of Exosome‐Derived Signature in TNBC : Integrating Single‐Cell and Bulk Transcriptomics for Prognosis Prediction
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Yuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shaanxi Provincial People's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Exosomes, Triple Negative Breast Neoplasms, Biomarkers, Tumor, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer with limited targeted therapeutic options. Exosomes, small membrane vesicles secreted by cells, play a crucial role in intercellular communication and material exchange. However, the role of exosome‐related genes (ERGs) in TNBC remains unclear. In here, we analyzed single‐cell RNA sequencing (scRNA‐seq) from 10 TNBC samples and bulk RNA‐seq from TCGA and METABRIC cohorts. Starting with 121 EDPS curated from the breast cancer‐specific ExoBCD database, we identified exosome‐active cell populations and derived an Exosome‐Derived Prognostic Signature (EDPS) through integrative machine learning. Our analysis identified 31,140 cells from TNBC samples, categorized into nine cell types, with epithelial cells exhibiting the highest exosome‐related scores. A total of 232 differentially expressed genes (DEGs) related to exosome‐related scores were identified, with 19 prognostic genes selected through univariate Cox regression, leading to the construction of an EDPS. Low EDPS scores correlated with poorer clinical outcomes, higher immune infiltrates, and immune‐related pathways. Furthermore, we identified notable differences in biological functions and mutation profiles between the two EDPS groups. Additionally, the low EDPS score group exhibited lower tumor immune dysfunction and exclusion (TIDE) scores, immunophenoscore (IPS), and higher immune checkpoint expression, suggesting better immunotherapy outcomes. In conclusion, while derived from exosome‐related genes, the EDPS primarily reflects immune‐active tumor microenvironments. This signature may help identify TNBC patients likely to benefit from immunotherapy, though further validation of its relationship to exosome biology is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shaanxi Provincial People's Hospital, Xi'an, China.
- Medical Laboratory Center, Shaanxi Provincial People's Hospital, Xi'an, China.
- Department of Radiation Oncology, Shaanxi Provincial People's Hospital, Xi'an, China.
ORCID-Profile: Yuan Zhang, Ming Zhao, Lei Hou, Long Jin, Jun Bai, Yunzhi Dang
Zitieren
APA
Zhang, Y., Zhao, M., Hou, L., Jin, L., Bai, J., & Dang, Y. (2025). Computational Analysis of Exosome‐Derived Signature in TNBC : Integrating Single‐Cell and Bulk Transcriptomics for Prognosis Prediction. Clinical and Translational Science. https://doi.org/10.1111/cts.70368
Vancouver
Zhang Y, Zhao M, Hou L, Jin L, Bai J, Dang Y. Computational Analysis of Exosome‐Derived Signature in TNBC : Integrating Single‐Cell and Bulk Transcriptomics for Prognosis Prediction. Clinical and Translational Science. 2025. doi:10.1111/cts.70368
BibTeX
@article{Zhang2025,
author = {Zhang, Yuan and Zhao, Ming and Hou, Lei and Jin, Long and Bai, Jun and Dang, Yunzhi},
title = {Computational Analysis of Exosome‐Derived Signature in TNBC : Integrating Single‐Cell and Bulk Transcriptomics for Prognosis Prediction},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70368}
}
EUVIMED